Arvinas and Pfizer to out-license vepdegestrant commercialization rights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. UNP
7. RNG
8. SPY
9. TMUS
10. ACI

Go back to Arvinas and Pfizer to out-license vepdegestrant commercialization rights
(NASDAQ: ARVN) Delayed: 8.02 -0.1 (1.23%)
Previous Close $8.12    52 Week High $ 
Open $8.11    52 Week Low $ 
Day High $8.16    P/E N/A 
Day Low $8.00    EPS $ 
Volume 195,300       

Pfizer Inc. (NYSE: PFE) Delayed: 24.62 +0.04 (0.16%)
Previous Close $24.58    52 Week High $37.39 
Open $24.62    52 Week Low $28.25 
Day High $24.75    P/E 14.92 
Day Low $24.52    EPS $1.65 
Volume 18,473,973